Mechanistically, we identified that tRF-Val directly bound to EEF1A1, mediated its transport into the nucleus, and promoted its interaction with MDM2, thus inhibiting the downstream molecular pathway of p53 and promoting GC progression. The gene discussed is MDM2; the disease is gastric cancer.